{"id":"https://openalex.org/W3182425369","doi":"https://doi.org/10.1158/1538-7445.am2021-1642","title":"Abstract 1642: A novel Fc\u03b3RIIB-blocking antibody to enhance Fc\u03b3R-dependent antitumor immunity","display_name":"Abstract 1642: A novel Fc\u03b3RIIB-blocking antibody to enhance Fc\u03b3R-dependent antitumor immunity","publication_year":2021,"publication_date":"2021-07-01","ids":{"openalex":"https://openalex.org/W3182425369","doi":"https://doi.org/10.1158/1538-7445.am2021-1642","mag":"3182425369"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2021-1642","doi":"https://doi.org/10.1158/1538-7445.am2021-1642","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2021-1642","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108728970","display_name":"Linda M\u00e5rtensson","orcid":"https://orcid.org/0009-0002-9518-7359","observed_orcids":["https://orcid.org/0009-0002-9518-7359"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Linda M\u00e5rtensson","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045250854","display_name":"Robert J. Oldham","orcid":"https://orcid.org/0000-0002-8007-1145","observed_orcids":["https://orcid.org/0000-0002-8007-1145"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Oldham","raw_affiliation_strings":["2Southampton University, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Southampton University, Southampton, United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007108884","display_name":"Marie Borggren","orcid":"https://orcid.org/0009-0001-0346-1676","observed_orcids":["https://orcid.org/0009-0001-0346-1676"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Marie Borggren","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023906837","display_name":"Mathilda Kovacek","orcid":"https://orcid.org/0009-0002-5156-7261","observed_orcids":["https://orcid.org/0009-0002-5156-7261"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mathilda Kovacek","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070337814","display_name":"Therese Blidberg","orcid":"https://orcid.org/0009-0004-1278-0830","observed_orcids":["https://orcid.org/0009-0004-1278-0830"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Therese Blidberg","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001529295","display_name":"Ali Roghanian","orcid":"https://orcid.org/0000-0003-1316-4218","observed_orcids":["https://orcid.org/0000-0003-1316-4218"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ali Roghanian","raw_affiliation_strings":["2Southampton University, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Southampton University, Southampton, United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086878160","display_name":"Ulla-Carin Thornberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ulla-Carin Thornberg","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065612884","display_name":"Ingrid Karlsson","orcid":"https://orcid.org/0009-0006-2466-919X","observed_orcids":["https://orcid.org/0009-0006-2466-919X"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ingrid Karlsson","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073058385","display_name":"Stephen A. Beers","orcid":"https://orcid.org/0000-0002-3765-3342","observed_orcids":["https://orcid.org/0000-0002-3765-3342"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen A. Beers","raw_affiliation_strings":["2Southampton University, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Southampton University, Southampton, United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076688601","display_name":"Mark Steven Cragg","orcid":"https://orcid.org/0000-0003-2077-089X","observed_orcids":["https://orcid.org/0000-0003-2077-089X"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark S. Cragg","raw_affiliation_strings":["2Southampton University, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Southampton University, Southampton, United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049258782","display_name":"Ingrid Teige","orcid":"https://orcid.org/0009-0007-5996-3396","observed_orcids":["https://orcid.org/0009-0007-5996-3396"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ingrid Teige","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013771543","display_name":"Bj\u00f6rn Frend\u00e9us","orcid":"https://orcid.org/0000-0003-3177-8686","observed_orcids":["https://orcid.org/0000-0003-3177-8686"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bjorn L. Frend\u00e9us","raw_affiliation_strings":["1BioInvent, Lund, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1BioInvent, Lund, Sweden;","institution_ids":["https://openalex.org/I4210141808"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"13_Supplement","first_page":"1642","last_page":"1642"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03689999878406525,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fc-gamma-receptor","display_name":"Fc gamma receptor","score":0.7080000042915344},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.7089999914169312},{"id":"https://openalex.org/keywords/treg-depletion","display_name":"Treg depletion","score":0.6919999718666077},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.527999997138977},{"id":"https://openalex.org/keywords/cancer-immunotherapy-resistance","display_name":"cancer immunotherapy resistance","score":0.6129999756813049},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.5879999995231628},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.6000000238418579},{"id":"https://openalex.org/keywords/fc-effector-functions","display_name":"Fc effector functions","score":0.4490000009536743},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.5},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.5460000038146973},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.3930000066757202},{"id":"https://openalex.org/keywords/pd-1-pd-l1","display_name":"PD-1/PD-L1","score":0.7049999833106995},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6087119579315186},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5712226629257202},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5702646970748901},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5408260822296143},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.539273738861084},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5339032411575317},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5255217552185059},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5179911851882935},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.497146874666214},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.48952826857566833},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.48312875628471375},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47531014680862427},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4729337990283966},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.4695504307746887},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41806408762931824},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11753106117248535}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2021-1642","doi":"https://doi.org/10.1158/1538-7445.am2021-1642","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2021-1642","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2003244776","https://openalex.org/W2922370696","https://openalex.org/W4248934506","https://openalex.org/W7171230655","https://openalex.org/W3126147677","https://openalex.org/W4399599991","https://openalex.org/W4313350105","https://openalex.org/W2323033593","https://openalex.org/W4379981819","https://openalex.org/W2115450015"],"abstract_inverted_index":{"Abstract":[0],"Therapeutic":[1],"antibodies":[2,21,186,245],"have":[3,343],"improved":[4],"survival":[5,357],"of":[6,78,184,218,283,314,318,381,424],"both":[7,111,191],"hematologic":[8],"and":[9,16,40,46,72,85,114,136,157,188,193,198,203,238,260,297,437],"solid":[10],"cancer":[11,48,92,105,134,201],"patients,":[12],"inducing":[13],"long-lasting":[14],"responses":[15],"even":[17],"cures.":[18],"Clinically":[19],"successful":[20],"exert":[22],"antitumor":[23,248,419],"activity":[24,130,151,183],"by":[25,38,107,250],"targeting":[26,39],"tumor":[27,52,113,143,364],"cells":[28,43,49,135,259],"directly":[29],"e.g.":[30],"anti-CD20":[31],"mAb":[32,195],"in":[33,50,152,163,169,227,320,358,378],"B":[34,132],"cell":[35,133],"cancer,":[36],"or":[37,64,159,323],"activating":[41],"immune":[42,115,262,327],"that":[44,177,243,308,352],"seek":[45],"destroy":[47],"the":[51,87,181,220,254,281,334,359,379,425],"microenvironment":[53],"(immune":[54],"checkpoint":[55,205,360],"blocking":[56,123],"antibodies;ICB).":[57],"Still,":[58],"many":[59],"patients":[60],"fail":[61],"to":[62,67,75,89,104,138,229,233,275,292,333,374,416],"respond":[63],"acquire":[65],"resistance":[66,74,103],"these":[68],"therapies.":[69],"Understanding":[70],"mechanisms":[71],"overcoming":[73],"distinct":[76],"classes":[77],"antibody":[79,124,289,415],"drugs,":[80],"is":[81,166],"therefore":[82,225],"clearly":[83],"warranted":[84],"has":[86],"potential":[88],"further":[90,350],"improve":[91],"outcomes.":[93],"The":[94],"inhibitory":[95],"Fc":[96],"gamma":[97],"receptor":[98],"(Fc\u03b3R)":[99],"IIB":[100],"may":[101,246],"precipitate":[102],"immunotherapy":[106],"several":[108],"mechanisms,":[109],"acting":[110],"on":[112,127,256],"effector":[116,258],"cells.":[117,268],"We":[118],"previously":[119],"developed":[120],"an":[121],"Fc\u03b3RIIB":[122,158],"(BI-1206).":[125],"Based":[126],"its":[128],"cytolytic":[129],"against":[131],"ability":[137],"block":[139],"rituximab":[140,149],"internalization":[141],"from":[142],"cells,":[144],"as":[145,147],"well":[146],"enhance":[148,375,417],"therapeutic":[150,182,208,222,312],"mice":[153],"humanized":[154],"for":[155,200,346,371,428],"CD20":[156],"bearing":[160],"relapsed/refractory":[161],"CLL":[162],"vivo,":[164],"BI-1206":[165],"being":[167],"explored":[168],"clinical":[170,240,335],"trials":[171],"(NCT03571568;":[172],"NCT04219254).":[173],"Emerging":[174],"data":[175,241],"demonstrate":[176,307,351],"Fc\u03b3Rs":[178],"can":[179],"modulate":[180],"ICB":[185,377],"(anti-PD-1/PD-L1":[187],"anti-CTLA-4).":[189],"While":[190],"anti-CTLA-4":[192,210,221,244,319,376],"anti-PD-1/L1":[194],"are":[196,212,224],"effective":[197],"approved":[199,345],"therapy,":[202],"combined":[204],"blockade":[206],"improves":[207],"responses,":[209],"therapies":[211,342],"associated":[213],"with":[214],"tolerability":[215],"issues.":[216],"Means":[217],"enhancing":[219],"window":[223],"desirable":[226],"order":[228],"deliver":[230],"this":[231],"therapy":[232,354],"more":[234],"patients.":[235],"Recent":[236],"preclinical":[237],"retrospective":[239],"indicate":[242],"promote":[247],"immunity":[249,420],"dual":[251],"mechanisms;":[252],"\u201creleasing":[253],"brakes\u201d":[255],"T":[257,265],"depleting":[261],"suppressive":[263],"intratumoral":[264],"regulatory":[266],"(Treg)":[267],"Anti-CTLA-4":[269],"induced":[270],"Treg":[271],"depletion":[272],"was":[273],"shown":[274],"be":[276],"Fc\u03b3R-dependent.":[277],"Here,":[278],"we":[279,306,349],"report":[280],"generation":[282],"a":[284,302],"novel,":[285],"fully":[286],"human":[287],"Fc\u03b3RIIB-blocking":[288,414],"(BI-1607)":[290],"engineered":[291],"eliminate":[293],"Fc-mediated":[294],"Fc\u03b3R":[295],"binding":[296],"function":[298],"(Fc-null":[299],"anti-Fc\u03b3RIIB).":[300],"Using":[301],"mechanism-of-action-matched":[303],"surrogate":[304],"antibody,":[305],"Fc-null":[309,372],"anti-Fc\u03b3RIIB":[310,373],"enhances":[311],"efficacy":[313],"submaximally":[315],"efficacious":[316],"doses":[317],"responsive":[321,362],"(MC38)":[322],"resistant":[324],"(CT26)":[325],"syngeneic":[326],"competent":[328],"mouse":[329],"models.":[330],"Of":[331],"relevance":[332],"setting":[336],"where":[337],"low":[338],"dose":[339],"anti-CTLA-4/anti-PD-1":[340],"combination":[341],"been":[344],"different":[347],"indications,":[348],"triplet":[353],"significantly":[355],"enhanced":[356],"blockade-poorly":[361],"B16":[363],"model.":[365],"Collectively":[366],"our":[367],"results":[368],"provide":[369],"proof-of-concept":[370],"treatment":[380],"cancer.":[382],"Citation":[383],"Format:":[384],"Linda":[385],"M\u00e5rtensson,":[386],"Robert":[387],"Oldham,":[388],"Marie":[389],"Borggren,":[390],"Mathilda":[391],"Kovacek,":[392],"Therese":[393],"Blidberg,":[394],"Ali":[395],"Roghanian,":[396],"Ulla-Carin":[397],"Thornberg,":[398],"Ingrid":[399,407],"Karlsson,":[400],"Stephen":[401],"A.":[402],"Beers,":[403],"Mark":[404],"S.":[405],"Cragg,":[406],"Teige,":[408],"Bjorn":[409],"L.":[410],"Frend\u00e9us.":[411],"A":[412],"novel":[413],"Fc\u03b3R-dependent":[418],"[abstract].":[421],"In:":[422],"Proceedings":[423],"American":[426],"Association":[427],"Cancer":[429,443],"Research":[430],"Annual":[431],"Meeting":[432],"2021;":[433],"2021":[434],"Apr":[435],"10-15":[436],"May":[438],"17-21.":[439],"Philadelphia":[440],"(PA):":[441],"AACR;":[442],"Res":[444],"2021;81(13_Suppl):Abstract":[445],"nr":[446],"1642.":[447]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2021-07-19T00:00:00"}